Affiliations
AffiliationsItem in Clipboard
Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published ResearchK Robin Yabroff et al. J Natl Cancer Inst. 2020.
. 2020 Jul 1;112(7):671-687. doi: 10.1093/jnci/djaa048. Authors K Robin Yabroff 1 , Katherine Reeder-Hayes 2 , Jingxuan Zhao 1 , Michael T Halpern 3 , Ana Maria Lopez 4 , Leon Bernal-Mizrachi 5 , Anderson B Collier 6 , Joan Neuner 7 , Jonathan Phillips 8 , William Blackstock 9 , Manali Patel 10 AffiliationsItem in Clipboard
AbstractBackground: Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations, but little is known about associations of disruptions with cancer care, including prevention, screening, and treatment, as well as outcomes of stage at diagnosis and survival.
Methods: We conducted a systematic review of studies of health insurance coverage disruptions and cancer care and outcomes published between 1980 and 2019. We used the PubMed, EMBASE, Scopus, and CINAHL databases and identified 29 observational studies. Study characteristics and key findings were abstracted and synthesized qualitatively.
Results: Studies evaluated associations between coverage disruptions and prevention or screening (31.0%), treatment (13.8%), end-of-life care (10.3%), stage at diagnosis (44.8%), and survival (20.7%). Coverage disruptions ranged from 4.3% to 32.8% of patients age-eligible for breast, cervical, or colorectal cancer screening. Between 22.1% and 59.5% of patients with Medicaid gained coverage only at or after cancer diagnosis. Coverage disruptions were consistently statistically significantly associated with lower receipt of prevention, screening, and treatment. Among patients with cancer, those with Medicaid disruptions were statistically significantly more likely to have advanced stage (odds ratios = 1.2-3.8) and worse survival (hazard ratios = 1.28-2.43) than patients without disruptions.
Conclusions: Health insurance coverage disruptions are common and adversely associated with receipt of cancer care and survival. Improved data infrastructure and quasi-experimental study designs will be important for evaluating the associations of federal and state policies on coverage disruptions and care and outcomes.
Published by Oxford University Press 2020. This work is written by US Government employees and is in the public domain in the US.
Similar articlesMalik AT, Alexander J, Khan SN, Scharschmidt TJ. Malik AT, et al. Clin Orthop Relat Res. 2021 Mar 1;479(3):493-502. doi: 10.1097/CORR.0000000000001438. Clin Orthop Relat Res. 2021. PMID: 32805094 Free PMC article.
Han X, Yabroff KR, Ward E, Brawley OW, Jemal A. Han X, et al. JAMA Oncol. 2018 Dec 1;4(12):1713-1720. doi: 10.1001/jamaoncol.2018.3467. JAMA Oncol. 2018. PMID: 30422152 Free PMC article.
Nguyen KH, Sommers BD. Nguyen KH, et al. Am J Public Health. 2016 Aug;106(8):1409-15. doi: 10.2105/AJPH.2016.303156. Epub 2016 May 19. Am J Public Health. 2016. PMID: 27196646 Free PMC article.
Slatore CG, Au DH, Gould MK; American Thoracic Society Disparities in Healthcare Group. Slatore CG, et al. Am J Respir Crit Care Med. 2010 Nov 1;182(9):1195-205. doi: 10.1164/rccm.2009-038ST. Am J Respir Crit Care Med. 2010. PMID: 21041563 Review.
Zhao J, Mao Z, Fedewa SA, Nogueira L, Yabroff KR, Jemal A, Han X. Zhao J, et al. CA Cancer J Clin. 2020 May;70(3):165-181. doi: 10.3322/caac.21604. Epub 2020 Mar 23. CA Cancer J Clin. 2020. PMID: 32202312 Review.
Oyer RA, Pierce L, Lathan C, Sagar B. Oyer RA, et al. Cancer J. 2022 Mar-Apr 01;28(2):134-137. doi: 10.1097/PPO.0000000000000580. Cancer J. 2022. PMID: 35333499 Free PMC article.
Abrahão R, Cooley JJP, Maguire FB, Parikh-Patel A, Morris CR, Schwarz EB, Wun T, Keegan THM. Abrahão R, et al. Int J Cancer. 2022 Apr 1;150(7):1113-1122. doi: 10.1002/ijc.33880. Epub 2021 Dec 8. Int J Cancer. 2022. PMID: 34800045 Free PMC article.
Snider NG, Hastert TA, Nair M, Kc M, Ruterbusch JJ, Schwartz AG, Peters ES, Stoffel EM, Rozek LS, Purrington KS. Snider NG, et al. Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):387-397. doi: 10.1158/1055-9965.EPI-22-0738. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36723416 Free PMC article.
Ji X, Hu X, Castellino SM, Mertens AC, Yabroff KR, Han X. Ji X, et al. JNCI Cancer Spectr. 2022 Jan 5;6(1):pkac006. doi: 10.1093/jncics/pkac006. JNCI Cancer Spectr. 2022. PMID: 35699500 Free PMC article.
Ibrahim R, Habib A, Terrani K, Ravi S, Takamatsu C, Salih M, Ferreira JP. Ibrahim R, et al. PLoS One. 2024 Jan 26;19(1):e0292167. doi: 10.1371/journal.pone.0292167. eCollection 2024. PLoS One. 2024. PMID: 38277379 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3